Deficiency in interferon-γ results in reduced body weight and better glucose tolerance in mice

Endocrinology

Volumn 152, Issue 10, 2011, Pages 3690-3699

  Wong, Nicole ^a   Fam, Barbara C ^a   Cempako, Gitta R ^a   Steinberg, Gregory R ^b,c   Walder, Ken ^d   Kay, Thomas W ^b   Proietto, Joseph ^a   Andrikopoulos, Sofianos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MCMASTER UNIVERSITY   (Canada)

^d DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; GAMMA INTERFERON; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; INSULIN; LEPTIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; ENZYME ACTIVITY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERINSULINEMIA; INSULIN SENSITIVITY; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; GLUCONEOGENESIS; GLUCOSE; INTERFERON-GAMMA; LIVER; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL;

EID: 80053148046     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0288     Document Type: Article

References (44)

1. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
2. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614 (Pubitemid 27446179)
3. Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB 2004 Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53:336-346 (Pubitemid 38174548)
4. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO 2002 Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79 (Pubitemid 34101732)
5. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW 1999 C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978 (Pubitemid 29177345)
6. Pamir N, McMillen TS, Kaiyala KJ, Schwartz MW, LeBoeuf RC 2009 Receptors for tumor necrosis factor-α play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology 150:4124-4134
7. Matthews VB, Allen TL, Risis S, Chan MH, Henstridge DC, Watson N, Zaffino LA, Babb JR, Boon J, Meikle PJ, Jowett JB, Watt MJ, Jansson JO, Bruce CR, Febbraio MA 2010 Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53:2431-2441
8. Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA 2004 Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 287:E182-E187 (Pubitemid 38856299)
9. Franckhauser S, Elias I, Rotter Sopasakis V, Ferré T, Nagaev I, Andersson CX, Agudo J, Ruberte J, Bosch F, Smith U 2008 Overexpression of IL6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 51:1306-1316
10. Chida D, Osaka T, Hashimoto O, Iwakura Y 2006 Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 55:971-977 (Pubitemid 44100171)
11. Garcia MC, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O, Horn M, Ahrén B, Enerback S, Ohlsson C, Wallenius V, Jansson JO 2006 Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 55:1205-1213 (Pubitemid 44195356)
12. Netea MG, Joosten LA, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ, Tack CJ, Van Krieken H, Kim SH, Stalenhoef AF, Van de Loo FA, Verschueren I, Pulawa L, Akira S, Eckel RH, Dinarello CA, Van den Berg W, Van der Meer JW 2006 Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 12:650-656 (Pubitemid 43865233)
13. Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, Stephens JM, Mynatt RL, Dixit VD 2010 Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 185:1836-1845
14. Kim CS, Lee SC, Kim YM, Kim BS, Choi HS, Kawada T, Kwon BS, Yu R 2008 Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity 16:1261-1269 (Pubitemid 351770531)
15. Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E, Chiesa C 2006 Increased T-helper interferon-γ-secreting cells in obese children. Eur J Endocrinol 154:691-697 (Pubitemid 43810855)
16. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, Libby P 2008 Interferon-γ, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 103:467-476
17. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA 1993 Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739-1742 (Pubitemid 23114658)
18. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TW, Nicola NA, Hertzog PJ, Metcalf D, Hilton DJ 1999 SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597-608 (Pubitemid 29418951)
19. Funkat A, Massa CM, Jovanovska V, Proietto J, Andrikopoulos S 2004 Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet. J Nutr 134:3264-3269 (Pubitemid 39602996)
20. Fam BC, Morris MJ, Hansen MJ, Kebede M, Andrikopoulos S, Proietto J, Thorburn AW 2007 Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity. Diabetes Obes Metab 9:840-852 (Pubitemid 47555205)
21. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J 2008 Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295:E1323-E1332
22. Lamont BJ, Visinoni S, Fam BC, Kebede M, Weinrich B, Papapostolou S, Massinet H, Proietto J, Favaloro J, Andrikopoulos S 2006 Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. Endocrinology 147:2764-2772 (Pubitemid 43764613)
23. Visinoni S, Fam BC, Blair A, Rantzau C, Lamont BJ, Bouwman R, Watt MJ, Proietto J, Favaloro JM, Andrikopoulos S 2008 Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver. Am J Physiol Endocrinol Metab 295:E1132-E1141
24. Andrikopoulos S, Rosella G, Gaskin E, Thorburn A, Kaczmarczyk S, Zajac JD, Proietto J 1993 Impaired regulation of hepatic fructose-1,6-bisphosphatase in the New Zealand obese mouse model of NIDDM. Diabetes 42:1731-1736 (Pubitemid 23346409)
25. Andrikopoulos S, Rosella G, Kaczmarczyk SJ, Zajac JD, Proietto J 1996 Impaired regulation of hepatic fructose-1,6-biphosphatase in the New Zealand Obese mouse: an acquired defect. Metabolism 45:622-626 (Pubitemid 26146116)
26. Steinberg GR, Watt MJ, Fam BC, Proietto J, Andrikopoulos S, Allen AM, Febbraio MA, Kemp BE 2006 Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 147:3906-3914 (Pubitemid 44079396)
27. Aston-Mourney K, Wong N, Kebede M, Zraika S, Balmer L, McMahon JM, Fam BC, Favaloro J, Proietto J, Morahan G, Andrikopoulos S 2007 Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia 50:2476-2485 (Pubitemid 350060635)
28. Li Y, Méchin MC, Van de Werve G 1999 Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase. J Biol Chem 274:33866-33868 (Pubitemid 129511712)
29. Kurosaki E, Nakano R, Momose K, Shimaya A, Suzuki T, Shibasaki M, Shikama H 2003 Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats. Eur J Pharmacol 468:151-158 (Pubitemid 36556258)
30. Borthwick EB, Houston MP, Coughtrie MW, Burchell A 2001 The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase. Horm Metab Res 33:721-726 (Pubitemid 34048834)
31. Massillon D, Barzilai N, Hawkins M, Prus-Wertheimer D, Rossetti L 1997 Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46:153-157 (Pubitemid 27009965)
32. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB 1998 Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620 (Pubitemid 28533186)
33. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH 2006 Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55:390-397 (Pubitemid 43343268)
34. Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, Juntti-Berggren L, Li LS, Van Rooijen N, Libert C, Berggren PO, Brüning JC 2010 Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab 12:237-249
35. Den Boer MA, Voshol PJ, Schröder-van der Elst JP, Korsheninnikova E, Ouwens DM, Kuipers F, Havekes LM, Romijn JA 2006 Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice. Endocrinology 147:4553-4558 (Pubitemid 44402159)
36. Kanemaki T, Kitade H, Kaibori M, Sakitani K, Hiramatsu Y, Kamiyama Y, Ito S, Okumura T 1998 Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27:1296-1303 (Pubitemid 28227856)
37. Senn JJ, Klover PJ, Nowak IA, Mooney RA 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399 (Pubitemid 35403441)
38. McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, Smyth EM, Reilly MP 2009 Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem 284:31936-31944
39. Wong N, Blair AR, Morahan G, Andrikopoulos S 2010 The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance. Endocrinology 151:96-102
40. Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T, Conti B 2007 Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 104:11097-11102 (Pubitemid 47175232)
41. Macia L, Viltart O, Delacre M, Sachot C, Héliot L, Di Santo JP, Wolowczuk I 2010 Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation. PLoS One 5:e9953
42. Morris DL, Rui L 2009 Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297:E1247-E1259
43. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW 2003 Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 26:557-562 (Pubitemid 36929307)
44. Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA 2008 Physical activity is associated with risk factors for chronic disease across adult women's life cycle. J Am Diet Assoc 108:948-959 (Pubitemid 351697881)